Begin main content

Reports

We found 5863 result(s)

Halobetasol propionate and tazarotene (Duobrii)

Last Updated: January 27, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: Halobetasol propionate and tazarotene
Indications: Psoriasis, moderate to severe plaque

  • Brand Name: Duobrii
  • Manufacturer: Bausch Health, Canada Inc.
  • Project Number: SR0638-000
  • Project Status: Received
  • Submission Type: New Combination

eculizumab (Soliris)

Last Updated: January 24, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: eculizumab
Indications: Neuromyelitis optica spectrum disorder

  • Brand Name: Soliris
  • Manufacturer: Alexion Pharma Canada Corp.
  • Project Number: SR0640-000
  • Project Status: Pending
  • Submission Type: New Indication

teduglutide (Revestive)

Last Updated: January 23, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: teduglutide
Indications: Short Bowel Syndrome (SBS), pediatrics

  • Brand Name: Revestive
  • Manufacturer: Shire Pharmaceuticals Ireland Limited
  • Project Number: SR0606-000
  • Project Status: Complete
  • Submission Type: New Indication

glucagon (Baqsimi)

Last Updated: January 24, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: glucagon
Indications: Severe hypoglycemic reactions

  • Brand Name: Baqsimi
  • Manufacturer: Eli Lilly Canada Inc.
  • Project Number: SR0626-000
  • Project Status: Active
  • Submission Type: New

caplacizumab (Cablivi)

Last Updated: January 24, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: caplacizumab
Indications: Acquired thrombotic thrombocytopenic purpura (aTTP)

  • Brand Name: Cablivi
  • Manufacturer: Sanofi-Genzyme, a division of sanofi-aventis Canada Inc.
  • Project Number: SR0633-000
  • Project Status: Active
  • Submission Type: New

budesonide (Jorveza)

Last Updated: January 24, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: budesonide
Indications: Eosinophilic esophagitis, adults

  • Brand Name: Jorveza
  • Manufacturer: AVIR Pharma Inc.
  • Project Number: SR0634-000
  • Project Status: Active
  • Submission Type: New

apomorphine hydrochloride (Kynmobi)

Last Updated: January 23, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: apomorphine hydrochloride
Indications: Parkinson’s Disease

  • Brand Name: Kynmobi
  • Manufacturer: Sunovion Pharmaceuticals Canada Inc.
  • Project Number: SR0604-000
  • Project Status: Withdrawn
  • Submission Type: New